cefixime has been researched along with Neoplasms in 5 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "Without cefixime, diarrhea was dose limiting at irinotecan 45 mg/m2/d." | 5.12 | Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. ( Billups, C; Crews, KR; Daw, NC; Dome, JS; Furman, WL; Gajjar, AJ; Houghton, PJ; Panetta, JC; Patrick, CC; Rodriguez-Galindo, C; Santana, VM; Stewart, CF; Wu, J, 2006) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "Febrile neutropenia is a heterogeneous condition." | 2.69 | Oral administration of cefixime to lower risk febrile neutropenic children with cancer. ( Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA, 2000) |
| "Shigella infection was diagnosed in 45 cancer patients." | 1.43 | Shigella infections: A two year experience in cancer patients. ( Mahboob, A; Nazeer, SH; Nizammudin, S; Raza, A; Sultan, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raza, A | 1 |
| Mahboob, A | 1 |
| Nizammudin, S | 1 |
| Nazeer, SH | 1 |
| Sultan, F | 1 |
| Furman, WL | 1 |
| Crews, KR | 1 |
| Billups, C | 1 |
| Wu, J | 1 |
| Gajjar, AJ | 1 |
| Daw, NC | 1 |
| Patrick, CC | 2 |
| Rodriguez-Galindo, C | 1 |
| Stewart, CF | 1 |
| Dome, JS | 1 |
| Panetta, JC | 1 |
| Houghton, PJ | 1 |
| Santana, VM | 2 |
| Paganini, HR | 1 |
| Sarkis, CM | 1 |
| De Martino, MG | 1 |
| Zubizarreta, PA | 1 |
| Casimir, L | 2 |
| Fernandez, C | 2 |
| Armada, AA | 1 |
| Rodriguez-Brieshcke, MT | 1 |
| Debbag, R | 2 |
| Shenep, JL | 1 |
| Flynn, PM | 1 |
| Baker, DK | 1 |
| Hetherington, SV | 1 |
| Hudson, MM | 1 |
| Hughes, WT | 1 |
| Roberson, PK | 1 |
| Sandlund, JT | 1 |
| Sixbey, JW | 1 |
| Slobod, KS | 1 |
| Paganini, H | 1 |
| Rodriguez-Brieshcke, T | 1 |
| Zubizarreta, P | 1 |
| Latella, A | 1 |
| Firpo, V | 1 |
| Armada, A | 1 |
| Cáceres, E | 1 |
4 trials available for cefixime and Neoplasms
| Article | Year |
|---|---|
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Cefixime; | 2006 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Chi | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
1 other study available for cefixime and Neoplasms
| Article | Year |
|---|---|
Shigella infections: A two year experience in cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Comorbidit | 2016 |